{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:26:55Z","timestamp":1792787215876,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10120-021-01180-x","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T09:04:49Z","timestamp":1616144689000},"page":"1021-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["EPRS\/GluRS promotes gastric cancer development via WNT\/GSK-3\u03b2\/\u03b2-catenin signaling pathway"],"prefix":"10.1007","volume":"24","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangaladoss","family":"Fredimoses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijia","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-7485","authenticated-orcid":false,"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"issue":"Suppl 1","key":"1180_CR1","doi-asserted-by":"crossref","first-page":"e12643","DOI":"10.1111\/hel.12643","volume":"24","author":"M Venerito","year":"2019","unstructured":"Venerito M, Link A, Rokkas T, Malfertheiner P. Review: gastric cancer-clinical aspects. Helicobacter. 2019;24(Suppl 1):e12643.","journal-title":"Helicobacter"},{"key":"1180_CR2","first-page":"1","volume":"61","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Human","year":"1994","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Human. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1\u2013241.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"1180_CR3","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","volume":"388","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet (London, England). 2016;388:2654\u201364.","journal-title":"Lancet (London, England)"},{"key":"1180_CR4","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24:1449\u201358.","journal-title":"Nat Med"},{"key":"1180_CR5","doi-asserted-by":"publisher","first-page":"15775","DOI":"10.1021\/bi001393h","volume":"39","author":"EJ Jeong","year":"2000","unstructured":"Jeong EJ, Hwang GS, Kim KH, Kim MJ, Kim S, Kim KS. Structural analysis of multifunctional peptide motifs in human bifunctional tRNA synthetase: identification of RNA-binding residues and functional implications for tandem repeats. Biochemistry. 2000;39:15775\u201382.","journal-title":"Biochemistry"},{"key":"1180_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ajhg.2018.02.011","volume":"102","author":"MI Mendes","year":"2018","unstructured":"Mendes MI, Gutierrez Salazar M, Guerrero K, Thiffault I, Salomons GS, Gauquelin L, et al. Bi-allelic mutations in EPRS, encoding the glutamyl-prolyl-aminoacyl-trna synthetase, cause a hypomyelinating leukodystrophy. Am J Hum Genet. 2018;102:676\u201384.","journal-title":"Am J Hum Genet"},{"key":"1180_CR7","doi-asserted-by":"publisher","first-page":"31682","DOI":"10.1074\/jbc.M909965199","volume":"275","author":"J Kang","year":"2000","unstructured":"Kang J, Kim T, Ko YG, Rho SB, Park SG, Kim MJ, et al. Heat shock protein 90 mediates protein-protein interactions between human aminoacyl-tRNA synthetases. J Biol Chem. 2000;275:31682\u20138.","journal-title":"J Biol Chem"},{"key":"1180_CR8","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1128\/MCB.01168-12","volume":"32","author":"A Arif","year":"2012","unstructured":"Arif A, Chatterjee P, Moodt RA, Fox PL. Heterotrimeric GAIT complex drives transcript-selective translation inhibition in murine macrophages. Mol Cell Biol. 2012;32:5046\u201355.","journal-title":"Mol Cell Biol"},{"key":"1180_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cell.2004.09.030","volume":"119","author":"P Sampath","year":"2004","unstructured":"Sampath P, Mazumder B, Seshadri V, Gerber CA, Chavatte L, Kinter M, et al. Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell. 2004;119:195\u2013208.","journal-title":"Cell"},{"key":"1180_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nature21380","volume":"542","author":"A Arif","year":"2017","unstructured":"Arif A, Terenzi F, Potdar AA, Jia J, Sacks J, China A, et al. EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice. Nature. 2017;542:357\u201361.","journal-title":"Nature"},{"key":"1180_CR11","doi-asserted-by":"publisher","first-page":"69592","DOI":"10.18632\/oncotarget.11870","volume":"7","author":"I Katsyv","year":"2016","unstructured":"Katsyv I, Wang M, Song WM, Zhou X, Zhao Y, Park S, et al. EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer. Oncotarget. 2016;7:69592\u2013605.","journal-title":"Oncotarget"},{"key":"1180_CR12","doi-asserted-by":"publisher","first-page":"21539","DOI":"10.1074\/jbc.M502462200","volume":"280","author":"SD Conner","year":"2005","unstructured":"Conner SD, Schmid SL. CVAK104 is a novel poly-L-lysine-stimulated kinase that targets the beta2-subunit of AP2. J Biol Chem. 2005;280:21539\u201344.","journal-title":"J Biol Chem"},{"key":"1180_CR13","doi-asserted-by":"publisher","first-page":"26716","DOI":"10.1074\/jbc.M109.039313","volume":"284","author":"T Terabayashi","year":"2009","unstructured":"Terabayashi T, Funato Y, Fukuda M, Miki H. A coated vesicle-associated kinase of 104 kDa (CVAK104) induces lysosomal degradation of frizzled 5 (Fzd5). J Biol Chem. 2009;284:26716\u201324.","journal-title":"J Biol Chem"},{"key":"1180_CR14","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.7150\/thno.46137","volume":"10","author":"H Liu","year":"2020","unstructured":"Liu H, Shin SH, Chen H, Liu T, Li Z, Hu Y, et al. CDK12 and PAK2 as novel therapeutic targets for human gastric cancer. Theranostics. 2020;10:6201\u201315.","journal-title":"Theranostics"},{"key":"1180_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/nar\/gkw1182","volume":"45","author":"A Chaliotis","year":"2017","unstructured":"Chaliotis A, Vlastaridis P, Mossialos D, Ibba M, Becker HD, Stathopoulos C, et al. The complex evolutionary history of aminoacyl-tRNA synthetases. Nucleic Acids Res. 2017;45:1059\u201368.","journal-title":"Nucleic Acids Res"},{"key":"1180_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1292\/jvms.20-0297","volume":"82","author":"T Saito","year":"2020","unstructured":"Saito T, Chambers JK, Nakashima K, Nibe K, Ohno K, Tsujimoto H, et al. Immunohistochemical analysis of beta-catenin, E-cadherin and p53 in canine gastrointestinal epithelial tumors. J Vet Med Sci. 2020;82:1277\u201386.","journal-title":"J Vet Med Sci"},{"key":"1180_CR17","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/stem.2702","volume":"35","author":"J Mao","year":"2017","unstructured":"Mao J, Liang Z, Zhang B, Yang H, Li X, Fu H, et al. UBR2 enriched in p53 deficient mouse bone marrow mesenchymal stem cell-exosome promoted gastric cancer progression via Wnt\/\u03b2-catenin pathway. Stem cells (Dayton, Ohio). 2017;35:2267\u201379.","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"1180_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11\u201326.","journal-title":"Nat Rev Cancer"},{"key":"1180_CR19","doi-asserted-by":"publisher","first-page":"e1000676","DOI":"10.1371\/journal.pgen.1000676","volume":"5","author":"CH Ooi","year":"2009","unstructured":"Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 2009;5:e1000676.","journal-title":"PLoS Genet"},{"key":"1180_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985\u201399.","journal-title":"Cell"},{"key":"1180_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mc.22292","volume":"55","author":"J Xu","year":"2016","unstructured":"Xu J, Chen Y, Huo D, Khramtsov A, Khramtsova G, Zhang C, et al. \u03b2-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. Mol Carcinog. 2016;55:431\u20139.","journal-title":"Mol Carcinog"},{"key":"1180_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12935-019-0883-1","volume":"19","author":"J Niu","year":"2019","unstructured":"Niu J, Li XM, Wang X, Liang C, Zhang YD, Li HY, et al. DKK1 inhibits breast cancer cell migration and invasion through suppression of \u03b2-catenin\/MMP7 signaling pathway. Cancer Cell Int. 2019;19:168.","journal-title":"Cancer Cell Int"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-021-01180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-021-01180-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-021-01180-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T09:43:46Z","timestamp":1698054226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-021-01180-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1180"],"URL":"https:\/\/doi.org\/10.1007\/s10120-021-01180-x","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed. Additional informed consent was obtained from all patients for which identifying information is included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}